Newsroom
AccessDx Lab to Exhibit at TXADONA 2024
AccessDx Laboratory is exhibiting at the upcoming TXADONA 2024 State Conference. The conference is taking place in Dallas, TX on September 25-26, 2024. We invite attendees of the conference to…
Read More
AccessDx Lab to Exhibit at SNN RETHINK 2024
AccessDx Laboratory is exhibiting at the upcoming SNN RETHINK Conference. The conference is taking place in Chicago, IL on September 11-12, 2024. We invite attendees of the conference to meet…
Read More
AccessDx Lab to Exhibit and Speak at IHCA/ICAL’s Annual Convention and Expo
AccessDx Laboratory is exhibiting at the upcoming 2024 IHCA/ICAL 74th Annual Convention & Expo. The conference is taking place in Peoria, Illinois on September 9-12, 2024 with the theme “Playbook…
Read More
AccessDx Lab to Exhibit at NADONA’s 37th Annual Conference
AccessDx Laboratory is exhibiting at the upcoming 2024 NADONA Annual Conference. This year, the conference is taking place in Kansas City, Missouri on June 23-26, 2024 with the theme “Follow…
Read More
PGx Biomarker Testing: Covered Soon for All Californians
Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is…
Read More
AccessDx Lab to Speak at the PMWC World Conference
AccessDx Laboratory's very own Federica Gibellini is a guest speaker at the upcoming PMWC World Conference 2024 in Silicon Valley, CA. We invite attendees to join Fede on January 24th…
Read More
Research Update: Tutorial on CYP2D6 Structural Variation Testing
Houda Hachad, VP of Clinical Operations at Aranscia, AccessDx Laboratory's parent company, is a co-author of the recent paper titled, "PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on…
Read More
Research Update: DPYD Genotyping Recommendations
Houda Hachad, VP of Clinical Operations at Aranscia, AccessDx Laboratory's parent company, commented on her recent co-authored paper released in The Journal of Molecular Diagnostics, "I am honored that I…
Read More
Research Update: CYP3A4 and CYP3A5 Genotyping Recommendations
Houda Hachad, VP of Clinical Operations at Aranscia, AccessDx Laboratory's parent company, is a co-author of the recent paper focusing on CYP3A4 and CYP3A5 genotyping recommendations in collaboration with the…
Read More
AccessDx Laboratory Launches Innovative UTI PROx Panel
AccessDx Laboratory Launches Innovative UTI PROx Panel PCR speed combined with culture-based insights to help maximize effective clinical treatment of UTI cases HOUSTON – April 26, 2023 - AccessDx Laboratory,…
Read More
Research Update: Comparison of Targeted vs. Expanded Pharmacogenomic Testing
Kristine Ashcraft, Founder and President of YouScript, an Aranscia company, recently co-authored a research paper titled, "Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?." Per the paper,…
Read More
